Healthcare
Live Price
Offline$0.0018
-28.00% today
Window Change
-91.82%
Window
Jun 30, 2025 → Dec 29, 2025
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 114 bars · Jun 30, 2025 → Dec 29, 2025
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Clene Inc. (CLNNW) is a Healthcare stock with a market cap of $2.16M. The stock last traded around $0.00 and down 91.8% across the available one-year price window (Jun 30, 2025 → Dec 29, 2025). Baseline metrics include revenue growth of -41.5%, EPS growth of +53.3%, a dividend yield of 0.0%. What stands out right now is revenue -41.5%, EPS +53.3%, free cash flow +12.9% with operating margin -11541.5% and ROIC -188.6%. Valuation already assumes a fairly strong business story at price/sales 329.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CLNNW price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
CLNNW is 103.15 pts behind over the shared 1Y window.
CLNNW had 86.78 pts deeper max drawdown than SPY.
CLNNW beat SPY in 0 of 1 calendar years shown and trailed in 1.
CLNNW
-91.82%
Normalized return
SPY
+11.33%
S&P 500
Excess Return
-103.15 pts
Relative to SPY
CLNNW Max Drawdown
-95.91%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for CLNNW and SPY.
| Year | CLNNW | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | — | +6.71% | -- | -- |
| 2025 | -91.82% | +11.19% | -103.01 pts | SPY |
Unable to load analyst forecasts.
Timed out loading forecasts for CLNNW
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.